Literature DB >> 597479

Usefulness of the SCM test in the diagnosis of gastric cancer.

F Takaku, T Yamanaka, Y Hashimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 597479      PMCID： PMC2025558          DOI： 10.1038/bjc.1977.266

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  6 in total

Review 1.  Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review.

Authors:  L Cercek; B Cercek
Journal:  Eur J Cancer       Date:  1977-09       Impact factor: 9.162

2.  Rapid preparation of lymphocytes for tissue-typing.

Authors:  R Harris; E O Ukaejiofo
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

3.  Structuredness of the cytoplasmic matrix and Michaelis-Menten constants for the hydrolysis of FDA during the cell cycle in Chinese hamster ovary cells.

Authors:  L Cercek; B Cercek; C H Ockey
Journal:  Biophysik       Date:  1973

4.  Isolation of an "antigen" from malignant tumours.

Authors:  P R Carnegie; E A Caspary; E J Field
Journal:  Br J Cancer Suppl       Date:  1973-08

5.  A common tumour specific antigen. II. Further characterization of the whole antigen and of a cross-reacting antigen of normal tissues.

Authors:  J P Dickinson; J R McDermott; J K Smith; E A Caspary
Journal:  Br J Cancer       Date:  1974-06       Impact factor: 7.640

6.  Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders.

Authors:  L Cercek; B Cercek; C I Franklin
Journal:  Br J Cancer       Date:  1974-05       Impact factor: 7.640
  6 in total
  4 in total

Review 1.  Fluorescent probes to detect lymphocyte activation.

Authors:  R C Nairn; J M Rolland
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

2.  Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases.

Authors:  Y Hashimoto; F Takaku; T Yamanaka
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

3.  Comments on "the SCM test for cancer. An evaluation in terms of lymphocytes from healthy donors and cancer patients".

Authors:  L Cercek; B Cercek
Journal:  Br J Cancer       Date:  1980-12       Impact factor: 7.640

4.  Response of T lymphocytes to phytohaemagglutinin (PHA) and to cancer-tissue-associated antigens, measured by the intracellular fluorescence polarization technique (SCM test).

Authors:  H Orjasaeter; G Jordfald; I Svendsen
Journal:  Br J Cancer       Date:  1979-10       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.